Il teacher. Fabrizio Vernieri, Associate of Neurology ofUniversità Campus Bio-Medico di Roma and Head of the Headache and Neurosonology Unit of the Campus Bio-Medico University Polyclinic Foundation, and his team won theEHF Award 2023 with The GARLIT Study. The paper involved 15 Italian headache centers e over 200 patients.
The research group tested new subcutaneously administered drugs, monoclonal antibodies that selectively bind an inflammatory protein, calcitonin gene-related peptide (CGRP), for the prevention of migraine attacks. "We are very proud of the result achieved. - says the professor. Painters - The new anti-CGRP drugs are well tolerated and very effective in treating the disease."